PhysioSol

PhysioSol was a biotechnology company that specialized in the development of advanced physiological solutions for tissue preservation and wound healing. Founded by experts in organ preservation, the company's core technology focused on maintaining cellular homeostasis and promoting tissue viability by mimicking the body's natural environment. Its lead products were utilized in the treatment of chronic wounds, such as diabetic foot ulcers, and in the preservation of kidneys and livers for transplantation. The company's assets were eventually acquired by Healthpoint and Organ Recovery Systems in the early 2000s, integrating its solutions into broader wound care and transplant portfolios.